Ashley Miller
Nurse Practitioner · Columbia, SCNPI 1346401965
Payments from drug & device makers
Across 135 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$701
- Johnson & Johnson$287
- Bristol Myers Squibb$237
- Pfizer$209
- Astellas Pharma US Inc$180
- E.r. Squibb & Sons, L.L.C.$141
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,83099%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $701 |
| Johnson & Johnson | 14 | $287 |
| Bristol Myers Squibb | 13 | $237 |
| Pfizer | 12 | $209 |
| Astellas Pharma US Inc | 9 | $180 |
| E.r. Squibb & Sons, L.L.C. | 8 | $141 |
| Merck | 5 | $140 |
| AbbVie | 7 | $135 |
| Janssen Scientific Affairs, LLC | 1 | $119 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Mayne Pharma Commercial LLC | 6 | $75 |
| Hologic Sales And Service, LLC | 3 | $74 |
| Array Biopharma Inc | 5 | $73 |
| EMD Serono, Inc. | 3 | $55 |
| Karyopharm Therapeutics Inc. | 2 | $40 |
| ADC Therapeutics America, Inc. | 2 | $35 |
| CTI Biopharma Corp. | 2 | $34 |
| Gilead | 1 | $29 |
| Sanofi | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Novocure Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| GSK | 1 | $16 |
| Seagen Inc. | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
| Eagle Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,859 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 125 | $2,053,400 |
| ErleadaApalutamide | 144 | $1,854,396 |
| PomalystPomalidomide | 29 | $641,260 |
| XtandiEnzalutamide | 55 | $599,654 |
| IbrancePalbociclib | 37 | $576,892 |
| CabometyxCabozantinib S-Malate | 15 | $337,440 |
| TalzennaTalazoparib Tosylate | 28 | $327,864 |
| ImbruvicaIbrutinib | 20 | $318,642 |
| BrukinsaZanubrutinib | 19 | $269,288 |
| Abiraterone Acetate | 57 | $225,139 |
| InqoviDecitabine/Cedazuridine | 16 | $131,666 |
| EliquisApixaban | 36 | $26,266 |
| XareltoRivaroxaban | 13 | $9,465 |
| Anastrozole | 65 | $2,422 |
| Imatinib Mesylate | 15 | $1,715 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $237 | $2,053,400125 claims |
| Johnson & JohnsonErleada, Xarelto | $287 | $1,863,861157 claims |
| PfizerIbrance, Talzenna, Eliquis | $209 | $931,021101 claims |
| E.r. Squibb & Sons, L.L.C.Pomalyst | $141 | $641,26029 claims |
| Astellas Pharma US IncXtandi | $180 | $599,65455 claims |
| Pharmacyclics LLC, An Abbvie CompanyImbruvica | $15 | $318,64220 claims |
| Beigene USA, Inc.Brukinsa | $14 | $269,28819 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $119 | $225,13957 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Columbia
- Jenna DavisColumbia$202K
- Melissa BramanteColumbia$19K
- Tonya MeltonColumbia$11K
- Andrea OatesColumbia$9K
- Meredith WatsonColumbia$9K
- Kimberly WillisColumbia$8K
- Leigh DavisColumbia$7K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.